Registered entities
CULLINAN ONCOLOGY, INC.
Reg. No. 1789972United States
CULLINAN ONCOLOGY, LLC
Reg. No. 81-3879991United States
Innovation
5 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 74 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 2 |
Investor mix
18 investors on record; lead investors include F2 Capital, Foresite Capital; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 61% |
| Private equity | 4 | 22% |
| Bank & private debt | 2 | 11% |
| Other / undisclosed | 1 | 6% |